ZOO Digital Group PLC (AIM: ZOO) — Investment Research Note

Executive summary

ZOO is a UK-listed, US-dollar-reporting provider of localisation (dubbing, subtitling) and digital media services to Hollywood studios and streaming platforms, using a proprietary cloud platform and a 12,000+ freelancer network. Revenue peaked at $90.3m in FY23 and has since fallen to $42.3m in FY26 as the Hollywood strikes, streamer content-budget resets and dubbing-mix shifts drove a two-year contraction; management responded with $14.4m of annual fixed-cost cuts, restoring adjusted EBITDA to $4.0m (FY25: $1.1m) at a 42% gross margin. The single most important valuation point is whether FY26 marks a genuine "rightsized" trough that inflects back to growth in FY27 (management guidance), or whether the structural threat from AI-driven localisation and customer concentration (top-two clients = 59% of revenue) makes the current run-rate the new normal.

Fair value estimate

• Methodology: EV/EBITDA on FY27 normalised run-rate, cross-checked against EV/Sales.
• Assumptions: FY27 revenue $44–48m (modest recovery in line with mgmt "return to growth" guidance 2026-07 final results), adjusted EBITDA $4.5–6.0m, apply 4–6x EV/EBITDA (small-cap, low-visibility, AI-exposed services multiple), add-back ~$2m net cash-equivalent position (cash $3.6m less borrowings $1.4m less lease liabilities in-year). USD/GBP at 0.75.
• Enterprise value range: $18m–$36m → £13.5m–£27m
• Equity fair value range: £14m–£28m → 14p – 28p per share (midpoint ~21p, implied mid-cap ~£20.7m)
• Vs. current £17.3m mcap (18.25p): implied upside of roughly +15% to midpoint, range from –23% (downside) to +53% (upside).

The share price has rallied 82% in the last 30 days from 10p, so the "screaming cheap" window has already partially closed; on the central case ZOO now sits in fair-value territory rather than deep value.

Sector context

• ICB classification (Technology / Technology) is technically correct but misleading — ZOO is really a specialised media-services outsourcer with an embedded software platform, closer to a BPO/creative-services hybrid than a SaaS company.
• Quality vs peers: below-average balance sheet (small net cash, accumulated losses of $77.8m, HSBC invoice financing central to going concern), average growth quality (revenue declining, restructuring-driven margin recovery), above-average technology differentiation for its niche (Fast Track, cloud platform, TPN Gold accreditation).
• Listed peers: RWS Holdings (LSE: RWS — larger, more diversified translation/localisation), Keywords Studios (recently taken private, but was closest listed comp), AppScatter/private Iyuno-SDI (dominant dubbing peer, private).

Investment thesis (3 bullets)

1. Rightsized operating base with in-built leverage: $14.4m of annual fixed cost has been permanently taken out; the business generated $4.0m adjusted EBITDA on $42.3m revenue vs. $1.1m EBITDA on $49.6m revenue the year before, showing the leaner cost base drops incremental revenue disproportionately to profit 2026-07 final results. A return to $50m revenue would plausibly generate ~$7–8m EBITDA.
2. Fast Track / accelerated fulfilment is a differentiated, higher-margin service that now accounts for ~10% of revenue and is aligned with structural streamer demand for live/near-live and episodic international content, giving ZOO a genuinely defensible niche vs. traditional studio-based competitors 2026-07 final results.
3. Turnaround optionality at a low absolute price: at £17.3m mcap on FY26 EBITDA of $4m (~£3m), the stock trades on ~5–6x EV/EBITDA with visible RFP wins across two new major studio customers announced in H2 FY26, plus new India (Chennai) capacity coming online at lower unit cost 2026-07 final results.

Key risks (3 bullets)

1. AI substitution risk to core dubbing/subtitling services: management's own risk section acknowledges third-party AI tools "have the potential to displace some of the services currently offered by the Group" 2026-07 final results. Slator's "medium-low" AI-adoption rating for premium film is a cushion, not a moat; commodity subtitling could compress fastest.
2. Customer concentration and demand volatility: top two clients represent 59% of FY26 revenue 2026-07 final results; a single UK customer's dubbing pullback caused most of the FY26 revenue decline. FY26H2 saw one-off library orders that "will not be replicated" — H2 revenue visibility remains limited.
3. Fragile balance sheet and going concern anchored on invoice financing: cash of $3.6m at year-end is against $14.3m current liabilities; going concern rests on renewal of HSBC invoice facilities ($5m US + £2m UK) and a stress-tested but implausible-worse-case model 2026-07 final results. A single quarter of adverse working-capital swings would tighten liquidity materially.

Operating leverage

The business has been deliberately re-engineered for high operating leverage. FY26 fixed operational cost base was $13.8m (excluding freelancer/variable costs), down from ~$23.2m two years earlier 2025-11 interim results. Gross margin at 42% (up from 36%) reflects both mix and reduced under-utilisation. The cost base now essentially fixed at "$14m + variable" against $42m revenue produces $4m EBITDA — a ~9.4% margin. On a 10% revenue beat to $46.5m at unchanged gross margin (42%) and flat fixed costs, gross profit rises by ~$1.8m, most of which drops to EBITDA — potentially lifting adjusted EBITDA to ~$5.8m (+45%). A 20% revenue beat to $50.7m would plausibly deliver ~$7.5m EBITDA (+88%). Real inflection points include: (a) the Chennai facility as marginal capacity, delivered at meaningfully lower unit cost; (b) Fast Track's premium pricing at similar cost; (c) the recently completed integration of international operations that removes duplicative overhead. This is a genuine high-operating-leverage story — but only if the revenue line actually re-inflects.

Value-trap signals

• Revenue decline of ~53% peak-to-trough ($90m → $42m) with FY27 growth still to be proven.
• Repeated guidance misses in the FY24–FY25 period (Feb 2025 update cut revenue guidance from $55m consensus to $50.5m; May 2025 cut it again to $49.4m; Q1 FY25 also warned of delays 2025-05 trading update; 2025-02 trading update).
• Joint venture impairments of $1.5m in FY26 and $1.5m in FY25 on Turkey/Spain investments — the geographic expansion story has partially failed to earn its cost of capital.
• Recurring restructuring / one-off items cloud "underlying" earnings quality; operating loss still $1.6m in FY26 despite adjusted EBITDA improvement.
• Cumulative equity destruction: accumulated losses of $77.8m against $70.8m of share premium — this is a business that has repeatedly raised capital and lost it.
• Customer concentration — a single UK client's dubbing decision materially changed FY26 outcomes.
• Structural AI overhang: management's own filing lists AI as a principal risk. Localisation is one of the more exposed knowledge-work verticals to agentic AI tooling.

Earnings vs. expectations

Across the period examined, ZOO's track record is mixed-to-negative: FY22–FY23 were strong beats driven by post-strike backlog and streamer international launches (H1 FY23 revenue +91% vs. H1 FY22 2022-11 interim results). From FY24 onwards the pattern reversed sharply — Jan 2024 warning that Q4 FY24 revenue would be "significantly lower than anticipated" 2024-01 trading update; Feb 2025 revenue guidance cut from $55m consensus to $50.5m 2025-02 trading update; May 2025 further cut to $49.4m 2025-05 trading update. FY26 was delivered in line with the (heavily reset) consensus of $42.3m revenue and $3.8m adjusted EBITDA (actual $4.0m — small beat) 2026-04 trading update; 2026-07 final results. Summary: three years of consecutive downgrades, followed by one meet/small beat against a low bar. Investors should demand more than one clean quarter before assuming the guidance culture has genuinely stabilised.

Conviction

3 — Moderate. Anchors: (a) FY26 results are audited, disclosure is unusually detailed for an AIM small-cap, and the cost-base restructuring is quantified in dollars ($14.4m taken out); (b) two independent valuation methods (EV/EBITDA and EV/Sales) converge on a similar range; (c) management commentary on FY27 pipeline is corroborated by named RFP wins. Limits: (i) genuine uncertainty on whether FY26 is the trough or a new plateau — the revenue line has been volatile for three years; (ii) structural AI risk is real and hard to size — a fair-value estimate that assumes conservative dubbing/subtitling pricing could be too generous if commodity AI localisation compresses market rates.

Fit to investor profile — driver reasoning summary

• AI beneficiary: This is a weakness, not a strength. ZOO uses AI internally to speed workflows but the primary financial risk is that AI-driven localisation tools substitute part of their revenue. Investor should treat this as an AI-exposed name, not an AI-receiver.
• Operating leverage: This is the strongest fit — high fixed cost base, capacity headroom, Fast Track pricing power, incremental revenue at ~42% gross margin drops largely to EBITDA.
• Valuation discipline: Reasonable fit at 10p, marginal at current 18.25p. The 82% one-month rally has consumed most of the discount; the current price already implies the FY27 recovery is underway.
• Downside protection: Weak — small cap, thin cash cushion, going-concern reliance on invoice financing, high customer concentration.

Net: interesting turnaround with genuine operating leverage but the wrong side of the AI trade and too fragile a balance sheet to earn a top-band score for this investor profile.